These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sildenafil extends survival and graft function in a large animal lung transplantation model. Korom S; Hillinger S; Cardell M; Zhai W; Tan Q; Dutly A; Leskosek B; Weder W Eur J Cardiothorac Surg; 2006 Mar; 29(3):288-93. PubMed ID: 16442298 [TBL] [Abstract][Full Text] [Related]
3. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb. Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698 [TBL] [Abstract][Full Text] [Related]
4. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits. Salloum FN; Ockaili RA; Wittkamp M; Marwaha VR; Kukreja RC J Mol Cell Cardiol; 2006 Mar; 40(3):405-11. PubMed ID: 16480739 [TBL] [Abstract][Full Text] [Related]
5. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model. du Toit EF; Rossouw E; Salie R; Opie LH; Lochner A Cardiovasc Drugs Ther; 2005 Jan; 19(1):23-31. PubMed ID: 15883753 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5. Das S; Maulik N; Das DK; Kadowitz PJ; Bivalacqua TJ Drugs Exp Clin Res; 2002; 28(6):213-9. PubMed ID: 12776574 [TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Fisher PW; Salloum F; Das A; Hyder H; Kukreja RC Circulation; 2005 Apr; 111(13):1601-10. PubMed ID: 15811867 [TBL] [Abstract][Full Text] [Related]
8. Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation. Reffelmann T; Kloner RA Cardiovasc Res; 2003 Aug; 59(2):441-9. PubMed ID: 12909327 [TBL] [Abstract][Full Text] [Related]
9. Sildenafil modulates hemodynamics and pulmonary gas exchange. Kleinsasser A; Loeckinger A; Hoermann C; Puehringer F; Mutz N; Bartsch G; Lindner KH Am J Respir Crit Care Med; 2001 Feb; 163(2):339-43. PubMed ID: 11179103 [TBL] [Abstract][Full Text] [Related]
10. PDE-5 inhibitor donor intravenous preconditioning is superior to supplementation in standard preservation solution in experimental lung transplantation. Pizanis N; Milekhin V; Tsagakis K; Aleksic I; Kamler M; Jakob H Eur J Cardiothorac Surg; 2007 Jul; 32(1):42-7. PubMed ID: 17482829 [TBL] [Abstract][Full Text] [Related]
11. Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection. Jamnicki-Abegg M; Weihrauch D; Chiari PC; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR J Cardiovasc Pharmacol; 2007 Dec; 50(6):670-6. PubMed ID: 18091584 [TBL] [Abstract][Full Text] [Related]
12. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. Kruuse C; Thomsen LL; Jacobsen TB; Olesen J J Cereb Blood Flow Metab; 2002 Sep; 22(9):1124-31. PubMed ID: 12218418 [TBL] [Abstract][Full Text] [Related]
13. Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil. Schneider F; Mattern-Dogru E; Hillgenberg M; Alken RG Arzneimittelforschung; 2007; 57(6):293-8. PubMed ID: 17688073 [TBL] [Abstract][Full Text] [Related]
14. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. Salloum FN; Takenoshita Y; Ockaili RA; Daoud VP; Chou E; Yoshida K; Kukreja RC J Mol Cell Cardiol; 2007 Feb; 42(2):453-8. PubMed ID: 17157308 [TBL] [Abstract][Full Text] [Related]
15. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227 [TBL] [Abstract][Full Text] [Related]
16. Treating pulmonary hypertension post cardiopulmonary bypass in pigs: milrinone vs. sildenafil analog. Urdaneta F; Lobato EB; Beaver T; Muehlschlegel JD; Kirby DS; Klodell C; Sidi A Perfusion; 2008 Mar; 23(2):117-25. PubMed ID: 18840581 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications. Kukreja RC; Salloum F; Das A; Ockaili R; Yin C; Bremer YA; Fisher PW; Wittkamp M; Hawkins J; Chou E; Kukreja AK; Wang X; Marwaha VR; Xi L Vascul Pharmacol; 2005; 42(5-6):219-32. PubMed ID: 15922255 [TBL] [Abstract][Full Text] [Related]
18. Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass. Szabó G; Radovits T; Veres G; Krieger N; Loganathan S; Sandner P; Karck M Eur J Cardiothorac Surg; 2009 Oct; 36(4):657-64. PubMed ID: 19523842 [TBL] [Abstract][Full Text] [Related]
19. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961 [TBL] [Abstract][Full Text] [Related]
20. Sildenafil reverses O2 constriction of the rabbit ductus arteriosus by inhibiting type 5 phosphodiesterase and activating BK(Ca) channels. Thébaud B; Michelakis E; Wu XC; Harry G; Hashimoto K; Archer SL Pediatr Res; 2002 Jul; 52(1):19-24. PubMed ID: 12084842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]